“Real-World Switch Rates for Patients With Psoriasis Initiating Risankizumab Stratified by Body Mass Index”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s248, https://doi.org/10.25251/skin.7.supp.248.